Serial Serum Albumin Estimation as a Prognostic Marker in Critically Ill Patients: A Prospective Observational Study from a Tertiary Care Hospital in Central India
DOI:
https://doi.org/10.21276/apjhs.2026.13.4.33Keywords:
Critical illness, Hypoalbuminemia, Intensive care units, Mortality, Prognosis, Serum albuminAbstract
Background: Serum albumin falls in critical illness and predicts mortality, but the value of serial measurements in Indian intensive care units (ICUs) is unclear. We evaluated serial serum albumin as a prognostic marker in critically ill adults. Materials and Methods: In this prospective observational study, 200 consecutive adults admitted to a tertiary ICU in Bhopal, India, had serum albumin measured on Day 1, Day 3, and Day 5. Severity was scored with the Acute Physiology and Chronic Health Evaluation II (APACHE II). Albumin levels, categories, and trends were compared between survivors and non-survivors (t-test, Chi-square test, relative risk [RR], and odds ratio [OR]). Results: Mortality was 24.0% (48/200), and 62.5% had hypoalbuminemia (<3.5 g/dL) on admission. Non-survivors had lower albumin than survivors at every time point (Day 1: 2.38 ± 0.82 vs. 3.38 ± 0.71 g/dL; Day 5: 2.29 ± 0.85 vs. 3.37 ± 0.71 g/dL; P < 0.001). Mortality rose from 9.3% with normal albumin to 60.0% with albumin <2.5 g/dL (P for trend <0.001; RR 6.43, 95% confidence interval [CI] 2.96–13.95). A deteriorating albumin trend carried an OR of 5.87 (95% CI 1.98–17.35) versus an improving trend. Albumin was lower in patients needing vasopressors but did not correlate with APACHE II score. Conclusion: Low and declining serum albumin was associated with higher mortality. Serial albumin estimation is inexpensive and may complement clinical assessment in resource-limited ICUs; multicenter studies with multivariable adjustment are needed.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Prashant Khuraiya, Vikas Kumar Sahu, Apurva Khare, Devendra P. S. Rajput, Yashovardhan Kag

This work is licensed under a Creative Commons Attribution 4.0 International License.
Asian Pacific Journal of Health Sciences applies the Creative Commons Attribution (CC-BY) license to published articles. Under this license, authors retain ownership of the copyright for their content, but they allow anyone to download, reuse, reprint, modify, distribute and/or copy the content as long as the original authors and source are cited. Appropriate attribution can be provided by simply citing the original article.

